Creative Medical Technology
CELZ
18 hedge funds and large institutions have $157K invested in Creative Medical Technology in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
6% more funds holding
Funds holding: 17 → 18 (+1)
0.13% less ownership
Funds ownership: 0.42% → 0.29% (-0.13%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
39% less capital invested
Capital invested by funds: $258K → $157K (-$101K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
+$41.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$8.28K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$7.1K |
| 4 |
SG
StoneX Group
New York
|
+$6.17K |
| 5 |
Morgan Stanley
New York
|
+$82 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$113K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$20.1K |
| 3 |
Millennium Management
New York
|
-$4K |
| 4 |
VF
Virtu Financial
New York
|
-$2.49K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2K |
CELZ Hedge Fund Activity: Q4 2022 in Review
18 of the 6,236 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q4 2022, worth a combined $157K — down 39% from $258K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELZ positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Aaron Wealth Advisors, opening a new position worth an estimated $41.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $113K sold.
- 18 institutional investors held Creative Medical Technology (CELZ) as of Q4 2022, up from 17 in Q3 2022.
- Funds reported $157K of Creative Medical Technology stock for Q4 2022, down 39% quarter-over-quarter.
- 4 funds opened new Creative Medical Technology positions in Q4 2022 and 3 closed out, a net change of +1 holder.
- The largest Creative Medical Technology buyer in Q4 2022 was Aaron Wealth Advisors, an estimated $41.2K added.
- The largest Creative Medical Technology seller in Q4 2022 was Citadel Advisors, an estimated $113K sold.
Based on aggregated 13F filings for Q4 2022.